The Simms/Mann - UCLA Center for Integrative Oncology is part of UCLA's Jonsson Comprehensive Cancer Center and UCLA Oncology. To find out more about research opportunities and medical oncology care, please visit these sites.


Phone: (310) 794-6644 Fax: (310) 794-9615
Mon - Fri: 8:00AM - 5:00PM Sat - Sun: Closed

Insights Into Cancer – July 9, 2019

Immunotherapy and Cancer

Presented by Bartosz Chmielowski, MD, PhD

About the Lecture

Immunotherapy is a type of cancer treatment that boosts the body’s natural defenses to fight cancer, using substances made by the body or in a laboratory to improve or restore immune system function. It is based on directing the body’s defense system to specifically attack cancer and is rapidly becoming an important modality in cancer treatment, in addition to surgery, radiation and chemical therapy. It can work in different ways, by stopping or slowing the growth of cancer cells, stopping cancer from spreading to other parts of the body, or helping the immune system work better at destroying cancer cells. In this lecture, Dr. Bartosz Chmielowski, UCLA Associate Professor, discusses the various types of immunotherapies, where they have been effectively utilized, and the future of immunotherapy for patients.

  • Monoclonal antibodies
  • Non-specific immunotherapies
  • Oncolytic virus therapy
  • T-cell therapy
  • Cancer vaccines

About the Speaker

Bartosz Chmielowski, MD, PhD, is an Associate Clinical Professor of Medicine in the Division of Hematology-Oncology at the University of California Los Angeles. He graduated from the Medical School at Wroclaw, Poland. He moved to the United States to pursue research career in immunology at the Medical College of Georgia in Augusta, GA where he concentrated on studying T cell development in the thymus. His research resulted in a PhD thesis. He completed his residency in Internal Medicine at the Medical College of Georgia in Augusta, GA, and did his fellowship in Hematology-Oncology at UCLA. Dr. Chmielowski has been a UCLA faculty member since 2008. Both his clinical and laboratory research concentrates on the development of new therapies for patients with melanoma and sarcoma.

Contact us for more information or book an appointment